Prime Global, a recognised global leader in medical communications and market access, has strengthened its Evidence, Access, and Patient Practice with the acquisition of HCD Economics, an academically aligned organisation focusing on health economics and outcomes research (HEOR) and real-world evidence (RWE). HCD will work closely with Prime Global’s highly experienced medical communications agencies and specialist consultancies, including market access consultancy, Prime Access, and patient engagement experts, Prime Patient, to deliver integrated evidence-led services.
read more >>Integrated services across the breadth of Evidence and Access
We offer the full spectrum of health economics, market access, value communications, and evidence generation delivery.
What we provide
Real World Evidence
Burden of disease studies
Chart reviews
Outcomes research
Database interrogation
Expert elicitation
Health Economics & Evidence Reviews
SLRs
HE models
Delphi panels
Publications
Market Access
Global value dossiers
Value communications
Objection handling
Payer insights
Pricing and strategy
Digital content
Who we are
Global team based across the US, UK, and Europe
Combined expertise from HCD Economics and Prime Access
Access to specialist in-house support from medical/technical writing, creative, digital, patient engagement, and more!
Why us?
Our combination of evidence generation and analytical expertise with specialist medical, patient, and payer communications skills helps you ensure patients have timely access to innovative treatments.
We can assist you in the development and execution of end-to-end solutions, from RWE and HEOR studies to strategic planning, traditional and innovative deliverables, and forward-thinking rollout campaigns.
Get in touch!
To discuss your evidence and access needs, please contact us on info@primeglobalpeople.com or use the form on our Contact Us page.
Contact us
Evidence and Access News.
-
Prime Global acquires HCD Economics, creating an innovative evidence-generating, HEOR, value & communications group
Prime Global 24 January, 2022Prime Global acquires HCD Economics, creating an innovative evidence-generating, HEOR, value & communications group -
The Digital Payer: Fact or Fiction?
Prime Global 21 October, 2021The Digital Payer: Fact or Fiction?Our experts, Sue O’Leary, Senior Vice President Prime Access, Jenny Blackham, Vice President Client Partnerships and Head of Digital Solutions Michelle Collins recently led a webinar with the team at NetworkPharma and MedComms Networking. Discussing ‘the digital payer – fact or fiction?’ the webinar was a brilliant platform to discuss perspectives and share ideas about about evolving payer communications in the changing digital landscape.
read more >> -
Overcoming the challenges of gene therapy
Prime Global 15 September, 2021Overcoming the challenges of gene therapyOnce considered science fiction, a number of different gene therapy approaches are now being adopted in clinical practice to target a range of diseases. Our Prime Omics team discuss ‘overcoming the challenges of gene therapy’ in their whitepaper. Read the full piece below.
read more >>